SCHEMBL2637595

SCHEMBL2637595

O=C(Nc1c(=O)[nH]n2c(=O)cc(-c3ccc(Cl)cc3)[nH]c12)c1ccccc1F

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.43
TP53 P04637 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
TDP1 Q9NUW8 2/20 0.42
KCNMA1 Q12791 1/20 0.42
PNLIP P16233 1/20 0.39
LMNA P02545 3/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TRPV1 Q8NER1 1/20 0.38
NR2E3 Q9Y5X4 1/20 0.38
PKM P14618 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
GAA P10253 1/20 0.37
HTT P42858 1/20 0.37
GRM5 P41594 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2637406 0.92 MAPT (0.41) MAPTTP53NPC1RAB9ASMN1; SMN2
SCHEMBL2637547 0.92 NPC1 (0.48) MAPTTP53NPC1RAB9ASMN1; SMN2
SCHEMBL2638375 0.90 MAPT (0.48) MAPTTP53NPC1RAB9ASMN1; SMN2
SCHEMBL2637556 0.85 POLB (0.46) MAPTNPC1RAB9ASMN1; SMN2TDP1
SCHEMBL2637889 0.85 KMT2A (0.46) MAPTNPC1RAB9AKCNMA1PNLIP
SCHEMBL2637343 0.77 ALDH1A1 (0.46) MAPTNPC1RAB9ASMN1; SMN2TDP1
SCHEMBL2637590 0.76 KDM4E (0.41) MAPTTP53NPC1RAB9ASMN1; SMN2
SCHEMBL2637331 0.76 KMT2A (0.47) MAPTNPC1RAB9AKCNMA1LMNA
SCHEMBL2637499 0.76 KMT2A (0.44) MAPTKCNMA1PNLIPLMNAMEN1
SCHEMBL2637478 0.76 HSP90AA1 (0.47) MAPTNPC1RAB9ATDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2438070-A1 GLYCINE B ANTAGONISTS Merz Pharma GmbH & Co. KGaA (DE) 2012-04-11 EP disclosed
WO-2010139483-A1 GLYCINE B ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2010-12-09 WO disclosed